Latest filing published 20 Nov 2015 for Sucampo Pharmaceuticals, Inc., €624.
Insider track record
No signal scores available.
Stanley G. Miele: trading record in brief
This profile gathers the share dealings of Stanley G. Miele in Sucampo Pharmaceuticals, Inc. In total, 5 filings cover trades dated from 16 May 2013 to 30 September 2015.
Every open-market trade on record is a sale: 2 sales worth €412k. Other entries cover 3 share grants.
The newest entry dates from 20 November 2015: a share grant of €624, in Sucampo Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stanley G. Miele
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 52 shares@ US$13.37Common Stock, Class A (ESPP)SEC:0001171843-15-006474:0
- 41 shares@ US$14.52Common Stock, Class A (ESPP)SEC:0001171843-15-006474:1
- 50,000 shares@ US$7.50Class A Common StockSEC:0001171843-13-004814:0
- 6,400 shares@ US$9.60Class A Common StockSEC:0001144204-13-030740:0
- 48,600 shares@ US$9.67Class A Common StockSEC:0001144204-13-030127:0
5 of 5 declarations
